Kalaris Therapeutics, Inc. KLRS
1.87 USD -0.03 (-1.58%)
Nov 12, 2026, 9:44 AM EST
1.87 Day range 1.90
1.78 52-week range 11.88
- YTD
- -77.84%
- 1 year
- -62.30%
- Market cap
- 44.52M
- EPS (ttm)
- -1.84
- YTD return
- -77.84%
- 1-year return
- -62.30%
- Volume
- 3.90K
- Avg volume
- 70.94K
- Open
- 1.90
- Previous close
- 1.90
- Day's range
- 1.87 – 1.90
- 52-week range
- 1.78 – 11.88
No chart data for this range yet.
Financials — quick view
KLRS Revenue — quarterly 0
KLRS Net income — quarterly -11.52M
KLRS EPS — quarterly -0.48
News
Citizens Maintains Market Outperform on Kalaris Therapeutics, Lowers Price Target to $20 
Kalaris Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate 
Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update 
Alpha Buying: 3 Beaten-Down Biotech Stocks Backed by a Specialist Investor 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
Kalaris Therapeutics Q2 EPS $(0.48) Beats $(0.49) Estimate - Kalaris Therapeutics Appoints Liisa Bayko CFO
Why Is Kalaris Therapeutics Stock Gaining Friday? 
12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on KLRS — it syncs with the Stock Master app.